Literature DB >> 20016284

The Drosophila retinoblastoma protein induces apoptosis in proliferating but not in post-mitotic cells.

Cécile Milet1, Aurore Rincheval-Arnold, Bernard Mignotte, Isabelle Guénal.   

Abstract

The retinoblastoma protein, pRb, plays important roles in many processes implicated in cell fate decisions, including cell cycle, differentiation and apoptosis. In cell cycle regulation, pRb interacts principally with the E2F transcription factor family members to inhibit the transcription of many genes controlling cell cycle progression. In this study, we focused on the role of pRb in apoptosis, which is much less clear than its role in cell cycle regulation. Indeed, pRb has been found to be either pro- or anti-apoptotic. To clarify how the proliferative status of the cells impacts the role of pRb in apoptosis, we used Drosophila to induce RBF (the pRb fly homologue) expression in different cellular and developmental contexts. We found that RBF expression induces apoptosis in different proliferative tissues in a caspase-dependent manner, whereas this effect was not observed in differentiated post-mitotic cells. Furthermore, RBF-induced apoptosis in proliferating cells was inhibited by co-expression of dE2F1, an antagonistic partner of RBF in cell cycle regulation. These results are in agreement with the view that the apoptotic properties of pRb are tightly linked to, and are probably a consequence of, an effect on cell cycle progression. Moreover, we show for the first time that RBF has a direct anti-apoptotic effect on Dmp53-induced cell death in post-mitotic cells only. Taken together, these data clearly show that RBF can exert a dual role in the control of apoptotic processes, and that its properties depend on the proliferative status of the cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20016284     DOI: 10.4161/cc.9.1.10251

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  8 in total

1.  Putting Rb in context with JNK.

Authors:  Beth Stronach
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Conserved RB functions in development and tumor suppression.

Authors:  Gabriel M Gordon; Wei Du
Journal:  Protein Cell       Date:  2011-12-17       Impact factor: 14.870

3.  Role of Drosophila retinoblastoma protein instability element in cell growth and proliferation.

Authors:  Jared S Elenbaas; Rima Mouawad; R William Henry; David N Arnosti; Sandhya Payankaulam
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  The retinoblastoma protein induces apoptosis directly at the mitochondria.

Authors:  Keren I Hilgendorf; Elizaveta S Leshchiner; Simona Nedelcu; Mindy A Maynard; Eliezer Calo; Alessandra Ianari; Loren D Walensky; Jacqueline A Lees
Journal:  Genes Dev       Date:  2013-04-25       Impact factor: 11.361

5.  Two different specific JNK activators are required to trigger apoptosis or compensatory proliferation in response to Rbf1 in Drosophila.

Authors:  Amandine Clavier; Aurore Rincheval-Arnold; Adrienne Baillet; Bernard Mignotte; Isabelle Guénal
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

6.  The pro-apoptotic activity of Drosophila Rbf1 involves dE2F2-dependent downregulation of diap1 and buffy mRNA.

Authors:  A Clavier; A Baillet; A Rincheval-Arnold; A Coléno-Costes; C Lasbleiz; B Mignotte; I Guénal
Journal:  Cell Death Dis       Date:  2014-09-04       Impact factor: 8.469

7.  Apoptosis Quantification in Tissue: Development of a Semi-Automatic Protocol and Assessment of Critical Steps of Image Processing.

Authors:  Juliette de Noiron; Marion Hoareau; Jessie Colin; Isabelle Guénal
Journal:  Biomolecules       Date:  2021-10-15

8.  Mutating RBF can enhance its pro-apoptotic activity and uncovers a new role in tissue homeostasis.

Authors:  Cécile Milet; Aurore Rincheval-Arnold; Angéline Moriéras; Amandine Clavier; Alexandrine Garrigue; Bernard Mignotte; Isabelle Guénal
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.